A sequential targeting strategy interrupts AKT-driven subclone-mediated progression in glioblastoma. Kebir S, Ullrich V, Berger P, Dobersalske C, et al. Clin Cancer Res 2022 Oct 14. pii: 709776. doi: 10.1158/1078-0432.CCR-22-0611.

Read + Share

Amedeo Smart

Independent Medical Education

Kebir S, Ullrich V, Berger P, Dobersalske C, et al. A sequential targeting strategy interrupts AKT-driven subclone-mediated progression in glioblastoma. Clin Cancer Res 2022 Oct 14. pii: 709776. doi: 10.1158/1078-0432.CCR-22-0611.
PMID: 36239995